Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Interim Management Statement

3 May 2012 11:00

RNS Number : 6576C
4imprint Group PLC
03 May 2012
 



3 May 2012

4imprint Group plc

AGM and Interim Management Statement

 

4imprint Group plc, the international promotional products Group, is today holding its Annual General Meeting and providing an interim management statement for the period from 1 January 2012 to 2 May 2012, incorporating information relating to the performance of the business for the period from 1 January 2012 to 31 March 2012.

 

Group revenue for the quarter from continuing operations was £37.48m, 15% ahead of prior year.

 

4imprint Direct Marketing

Revenue in 4imprint Direct Marketing for the first quarter was £33.98m, 15% ahead of prior year. North American revenue in quarter one was US$51.05m, 14% ahead of prior year. The average USD exchange rate in the quarter was $1.57 (2011:$1.60).

 

In North America, orders from previously acquired customers increased by 21% over prior year as repurchase rates remained consistent with those achieved in the prior year. New customer acquisition was also consistent with marketing activity and prior year yield. Over 30,500 new customers were acquired during the quarter. The UK Direct Marketing operation showed positive progress with sales 6% ahead of the prior year period.

 

SPS

Total revenue in SPS was £3.83m, 10% ahead of the first quarter of the prior year. Orders for both manufactured and purchased products showed the benefit of more focused sales and marketing activity.

 

Brand Addition sale

The conditions relating to the sale of Brand Addition were met in March and completion took place on 23 March 2012. Initial gross consideration of £21.49m, after adjusting for the estimated value of working capital and net cash in the business at the date of sale, was received. An unconditional, deferred payment of £1.25m is due for receipt in March 2013.

 

£11.4m of the sale proceeds received were transferred to the legacy pension fund on 2 April 2012. This amount will initially be held in cash, whilst the Company and the Trustee investigate pension risk reduction options.

 

Board

In accordance with best practice, all directors are proposed annually for re-election. During 2012, both Ian Brindle and Nick Temple will have served for nine years and they will retire from the Board during the coming months. An appointment process for two new Non-Executive Directors is well advanced.

 

 

 

Outlook

The positive momentum demonstrated by the business over the course of last year has continued into 2012 and, subject to continued stable economic conditions in US, the Board anticipates further organic growth in line with its goal of doubling the Direct Marketing business over the next five years.

 

 

 

For further information please contact:

John Poulter, Chairman

Gillian Davies, Group Finance Director

 

Tel: + 44 (0) 20 7299 7201

 

 

 

About 4imprint Group plc

 

4imprint Group plc is a UK listed promotional products Group with two operations: 4imprint Direct Marketing and SPS.

4imprint Direct Marketing supplies an extensive range of promotional products and branded apparel to a wide variety of businesses and organisations throughout the USA, Canada, UK and Ireland.

 

SPS supplies promotional and advertising products to distributors within the promotional products industry who then sell these products on to end users.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGCGDUXBGBGDX
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.